5.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average – Should You Sell? - Defense World
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
(FENC) Investment Analysis and Advice - news.stocktradersdaily.com
Fennec Pharmaceuticals Achieves Strong Growth and Expands Market Reach in 2024 - TipRanks
Long Term Trading Analysis for (FRX) (FRX:CA) - news.stocktradersdaily.com
(FRX) Stock Market Analysis (FRX:CA) - news.stocktradersdaily.com
(FENC) Technical Data - news.stocktradersdaily.com
(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com
Q1 EPS Forecast for Fennec Pharmaceuticals Raised by Analyst - Defense World
HC Wainwright Has Positive Forecast for TSE:FRX Q1 Earnings - Defense World
Wedbush Research Analysts Boost Earnings Estimates for FENC - Defense World
What is HC Wainwright’s Forecast for FENC Q1 Earnings? - Defense World
US$12.60: That's What Analysts Think Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Is Worth After Its Latest Results - Simply Wall St
Wedbush Boosts Earnings Estimates for Fennec Pharmaceuticals - Defense World
Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Thursday - Defense World
Fennec Pharmaceuticals: Strong Growth Potential with PEDMARK’s Market Expansion and Strategic Focus - TipRanks
Fennec Pharmaceuticals (NASDAQ:FENC) Receives Buy Rating from HC Wainwright - Defense World
Fennec Pharmaceuticals Reports Strong Growth Amid Challenges - TipRanks
Fennec Pharmaceuticals: Strategic Market Expansion and Financial Performance Justify Buy Rating - TipRanks
(FRX) Technical Data (FRX:CA) - news.stocktradersdaily.com
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript - Insider Monkey
Rhumbline Advisers Grows Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (NASDAQ:FENC) Receives “Outperform” Rating from Wedbush - Defense World
Fennec Pharmaceuticals Reports Strong 2024 Sales Growth - TipRanks
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView
Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts By Investing.com - Investing.com South Africa
Wedbush Reviews Fennec Pharmaceuticals' Q4 -March 10, 2025 at 12:48 pm EDT - Marketscreener.com
Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% By Investing.com - Investing.com Canada
Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% - Investing.com
Fennec Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts - Investing.com
Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain - Yahoo Finance
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Fennec Pharmaceuticals Reports Strong 2024 Financials and Expands Global Reach - TipRanks
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Manila Times
FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings - Nasdaq
Earnings Flash (FRX.TO) Fennec Pharmaceuticals Posts Q4 Revenue US$7.925 Million - Marketscreener.com
Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates - Nasdaq
Earnings Scheduled For March 10, 2025 - Benzinga
Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Monday - Defense World
Fennec Pharmaceuticals director Raykov sells $67,900 in stock By Investing.com - Investing.com Canada
Fennec Pharmaceuticals director Raykov sells $67,900 in stock - Investing.com
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025 - The Manila Times
Trading (FENC) With Integrated Risk Controls - Stock Traders Daily
(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily
Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily
Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat
(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):